α2-Adrenergic agonist; centrally active myotonolytic. Prepn and antitremor activity: P. Neumann, NL 7306228; eidem, US 3843668 (1973, 1974 both to Wander-Sandoz). Pharmacology: A. C. Sayers et al., Arzneim.-Forsch. 30, 793 (1980); and mechanism of action studies: L. Turski et al., Brain Res. 379, 367 (1986); H. Ono et al., Gen. Pharmacol. 17, 137 (1986). Pharmacokinetics: V. Heazlewood et al., Eur. J. Clin. Pharmacol. 25, 65 (1983). Clinical evaluation in spasticity of multiple sclerosis: P. M. Newman et al., ibid. 23, 31 (1982); M. C. Hoogstraten et al., Acta Neurol. Scand. 77, 224 (1988).
Muscle relaxant (skeletal).
Muscle Relaxant (Skeletal)